These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 34379145)
1. [Epidemiology and treatment of adult patients with atopic dermatitis : Analysis of longitudinal data of the statutory health insurance scheme]. Zietze HA; Cabral C; Theobald K; Ihle P; Pittrow D; Kienitz C; Augustin M Hautarzt; 2021 Nov; 72(11):963-974. PubMed ID: 34379145 [TBL] [Abstract][Full Text] [Related]
2. Incidence Trends of Atopic Dermatitis in Infancy and Early Childhood in a Nationwide Prescription Registry Study in Norway. Mohn CH; Blix HS; Halvorsen JA; Nafstad P; Valberg M; Lagerløv P JAMA Netw Open; 2018 Nov; 1(7):e184145. PubMed ID: 30646341 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and Medications of Atopic Dermatitis in Germany: Claims Data Analysis. Hagenström K; Sauer K; Mohr N; Dettmann M; Glaeske G; Petersen J; Garbe C; Steimle T; Augustin M Clin Epidemiol; 2021; 13():593-602. PubMed ID: 34321929 [TBL] [Abstract][Full Text] [Related]
4. Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis. Hagenström K; Klinger T; Müller K; Willers C; Augustin M Br J Dermatol; 2024 Oct; 191(5):719-727. PubMed ID: 38924726 [TBL] [Abstract][Full Text] [Related]
5. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden. Katoh N; Saeki H; Kataoka Y; Etoh T; Teramukai S; Takagi H; Tajima Y; Ardeleanu M; Rizova E; Arima K; J Dermatol; 2019 Apr; 46(4):290-300. PubMed ID: 30756423 [TBL] [Abstract][Full Text] [Related]
6. [Current and upcoming treatments of adult atopic dermatitis]. Lacour JP Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635 [TBL] [Abstract][Full Text] [Related]
7. Treatment patterns of pediatric patients with atopic dermatitis: A claims data analysis. Paller AS; Siegfried EC; Vekeman F; Gadkari A; Kaur M; Mallya UG; Héroux J; Miao R; Mina-Osorio P J Am Acad Dermatol; 2020 Mar; 82(3):651-660. PubMed ID: 31400453 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, incidence and management of atopic dermatitis in Australian general practice using routinely collected data from MedicineInsight. Chidwick K; Busingye D; Pollack A; Osman R; Yoo J; Blogg S; Rubel D; Smith S Australas J Dermatol; 2020 Aug; 61(3):e319-e327. PubMed ID: 32173859 [TBL] [Abstract][Full Text] [Related]
9. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey. Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965 [TBL] [Abstract][Full Text] [Related]
10. Effects of variations in access to care for children with atopic dermatitis. Siegfried EC; Paller AS; Mina-Osorio P; Vekeman F; Kaur M; Mallya UG; Héroux J; Miao R; Gadkari A BMC Dermatol; 2020 Dec; 20(1):24. PubMed ID: 33341118 [TBL] [Abstract][Full Text] [Related]
11. [Regional variations in healthcare for patients with psoriasis and atopic dermatitis in Germany]. Augustin M; Garbe C; Neitemeier S; Steimle T; Schwarz S; Augustin J; von Kiedrowski R; Hagenström K Hautarzt; 2022 Jan; 73(1):27-39. PubMed ID: 34821976 [TBL] [Abstract][Full Text] [Related]
12. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany. Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987 [TBL] [Abstract][Full Text] [Related]
13. Systemic Agents for Severe Atopic Dermatitis in Children. Notaro ER; Sidbury R Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214 [TBL] [Abstract][Full Text] [Related]
15. Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution? Alexander H; Patton T; Jabbar-Lopez ZK; Manca A; Flohr C F1000Res; 2019; 8():. PubMed ID: 30774935 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Frankel HC; Qureshi AA Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704 [TBL] [Abstract][Full Text] [Related]
17. Treatment of adult atopic dermatitis patients according to disease characteristics and demographics. Thyssen JP; Andersen YMF; Vittrup I; Pierce E; DeLozier A; Egeberg A Dermatol Ther; 2020 Nov; 33(6):e14439. PubMed ID: 33084105 [TBL] [Abstract][Full Text] [Related]
18. Systemic therapy of atopic dermatitis in children. Ricci G; Dondi A; Patrizi A; Masi M Drugs; 2009; 69(3):297-306. PubMed ID: 19275273 [TBL] [Abstract][Full Text] [Related]
19. Real-World Outpatient Prescription Patterns for Atopic Dermatitis in the United States. Singh P; Silverberg J Dermatitis; 2019; 30(5):294-299. PubMed ID: 31524757 [TBL] [Abstract][Full Text] [Related]
20. Therapy of atopic eczema. Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]